Inogen (NASDAQ:INGN) Cut to Hold at StockNews.com

StockNews.com cut shares of Inogen (NASDAQ:INGN) from a buy rating to a hold rating in a research report released on Friday morning.

Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research report on Friday, November 8th.

Inogen Trading Up 2.0 %

Inogen stock opened at $8.48 on Friday. The company has a fifty day simple moving average of $9.46 and a 200-day simple moving average of $9.74. The stock has a market cap of $201.98 million, a P/E ratio of -3.77 and a beta of 1.02. Inogen has a 12-month low of $5.08 and a 12-month high of $13.33.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of INGN. Bank of New York Mellon Corp lifted its position in Inogen by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 97,132 shares of the medical technology company’s stock valued at $790,000 after acquiring an additional 7,240 shares during the last quarter. Panagora Asset Management Inc. acquired a new stake in shares of Inogen in the 2nd quarter valued at about $256,000. Monaco Asset Management SAM purchased a new position in Inogen during the 2nd quarter worth approximately $610,000. American Century Companies Inc. grew its stake in Inogen by 33.2% during the 2nd quarter. American Century Companies Inc. now owns 38,627 shares of the medical technology company’s stock worth $314,000 after buying an additional 9,626 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in Inogen during the second quarter worth approximately $30,000. Institutional investors and hedge funds own 89.94% of the company’s stock.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.